RCTJadad 5/5RandomizedDouble-BlindPlacebo-Controlled

Ashwagandha + HIIT: An 8-Week Trial Finds the Popular "Adaptogen Stack" Adds Nothing to Cholesterol, Body Composition, or Exercise Hormones

NutrientsOctober 16, 2025Vol. 17 (20)

Summary

If you've stacked ashwagandha into your training routine hoping it would amplify your cardio gains, this new study is worth a hard look. Researchers in Poland ran an 8-week, randomized, double-blind, placebo-controlled trial (Jadad score 5/5 — as rigorous as this type of design gets) in 41 healthy young men, mostly physical education students. Everyone did the same 3x/week high-intensity interval training (HIIT) program on a rowing ergometer, working up to 85–95% of their max power. Half also took 600 mg/day of KSM-66 ashwagandha root extract (a well-known, standardized commercial ingredient you'll recognize on supplement labels); the other half took an identical-looking placebo capsule. Neither participants nor (implicitly) assessors knew who got what.

Why care? Ashwagandha is one of the best-selling adaptogen supplements in the U.S. and Europe, marketed heavily for stress reduction, testosterone, muscle strength, and "metabolic health." Several smaller trials — including a widely cited 2015 study and newer 2024–2025 KSM-66-funded research — have reported that ashwagandha plus resistance training boosts strength, muscle size, and reduces body fat compared to training alone. This study asked a narrower, useful question: does adding ashwagandha to a cardio-based HIIT program change body composition, blood lipids, or the specific hormones that regulate fat and muscle metabolism (adiponectin, asprosin, and irisin)?

The answer, after 8 weeks: no. Body weight, fat mass, muscle mass, and total body water didn't change meaningfully in either group. Total cholesterol, HDL, LDL, and triglycerides all trended down or up slightly but not significantly, with no difference between ashwagandha and placebo. On the hormone side, the HIIT program itself did something real — it significantly lowered resting adiponectin levels and significantly raised irisin (the "exercise hormone" linked to fat browning and muscle-bone crosstalk) both immediately after exercise and 24 hours later (p < 0.0001 for the irisin time effect). But layering ashwagandha on top of that training response changed nothing — the herb group and placebo group moved in lockstep. Asprosin, a newer metabolic hormone linked to fasting and insulin resistance, wasn't significantly affected by either training or supplementation.

The bigger picture: HIIT training clearly reshapes how your body handles fat- and muscle-signaling hormones in as little as 8 weeks, even in already-lean, physically active young men. Ashwagandha, at least at this dose, duration, and in this specific population, didn't add an extra metabolic edge on top of that training effect — even though earlier resistance-training studies using nearly identical doses (600 mg/day KSM-66) found strength and body-composition benefits. That contrast is itself informative: ashwagandha's reported benefits may be more tied to resistance/strength training contexts than to cardio-based interval work.

Sources: Nutritional Outlook on KSM-66 strength study, Frontiers systematic review on HIIT and exerkines

What This Means For You

If you're doing HIIT-style cardio (rowing, cycling, running intervals) and considering ashwagandha specifically to boost fat loss, cholesterol, or "metabolic hormone" outcomes, this trial suggests you shouldn't expect an added benefit beyond what the training itself provides — at 600 mg/day of standardized KSM-66 extract (5% withanolides) for 8 weeks. The training alone was doing real work: measurable shifts in adiponectin and a large, reliable irisin response. That's a good reminder that consistent interval training is the active ingredient most people are actually looking for.

Where ashwagandha still has more supportive evidence is in resistance/strength training contexts — several trials using the same 600 mg/day KSM-66 dose alongside weightlifting have reported gains in strength, lean mass, and reduced body fat, plus stress/cortisol and sleep benefits unrelated to exercise at all. So if your goal is strength gains, recovery, or stress management, existing (if still limited) evidence is more favorable than what this cardio-focused study found.

Practical buying/dosing notes: this study used a specific, well-characterized product (KSM-66, standardized to 5% withanolides, 300 mg twice daily with meals) — if you try ashwagandha, matching that standardization and dose range (500–600 mg/day) is what the literature actually supports, rather than assuming all "ashwagandha" capsules are equivalent. Tolerability was excellent — no adverse events in either group over 8 weeks — so safety isn't the concern here; efficacy for this specific use case is. People with thyroid conditions, on sedative/anti-anxiety medications, or who are pregnant should still check with a doctor, since ashwagandha can affect thyroid hormones and has sedative properties, even though this study excluded such people entirely.

Important Considerations

This trial has real strengths — full randomization with computer-generated allocation, double-blinding with a genuinely indistinguishable placebo, and a Jadad quality score of 5 out of 5, meaning it's methodologically about as solid as this study type gets. But several limits matter for translating it to your own routine.

First, the population: 41 healthy, lean, physically active young men (physical education students) in Poland. Nothing here tells you what happens in women, older adults, overweight/obese individuals, or people with actual metabolic dysfunction (elevated cholesterol, insulin resistance) — populations where ashwagandha's metabolic effects have shown more promise in other research. Baseline HDL was already quite high (70–80 mg/dL) in this group, leaving little room for improvement either way.

Second, 8 weeks may simply be too short — the authors themselves note that a longer supplementation period might be needed to see benefits in an already-fit population doing intense training, and diet was self-reported (a known source of bias) rather than controlled.

Third, three participants dropped out (7.3%), and the sample, while meeting the pre-specified power calculation (n=34), is still modest — a bigger trial might catch smaller effects this one wasn't powered to detect. There's also no clinical trial registry entry noted, so pre-registration/protocol transparency is unclear. And a genuine research gap: no prior study had combined ashwagandha with HIIT specifically, so there's nothing directly comparable to weigh this against — it stands alone for now. Treat any supplement marketing claiming ashwagandha will supercharge your cardio training's metabolic benefits with real skepticism until larger, longer, more diverse trials weigh in.

Terms Explained

Ashwagandha (Withania somnifera)An Ayurvedic herb, also called Indian ginseng, marketed as an adaptogen for stress, sleep, testosterone, and muscle recovery support.
KSM-66A specific, patented, full-spectrum ashwagandha root extract standardized to a set concentration of withanolides, commonly used in commercial supplements and clinical trials.
WithanolidesThe main active steroidal compounds in ashwagandha root, used to standardize extract potency (e.g., "5% withanolides").
HIIT (High-Intensity Interval Training)A training method alternating short bursts of near-maximal effort with lower-intensity recovery periods, known for time-efficient cardiovascular and metabolic benefits.
AdiponectinA hormone released by fat tissue that improves insulin sensitivity and has anti-inflammatory effects; generally, higher levels are considered metabolically favorable.
IrisinA hormone released by muscle during exercise (a "myokine") linked to fat-tissue browning, bone health, and exercise adaptation.
AsprosinA more recently discovered hormone released during fasting that raises blood glucose; elevated levels have been linked to obesity and insulin resistance.
Double-blind, placebo-controlledA study design where neither participants nor researchers know who received the real treatment versus an inactive look-alike, reducing bias in reported results.
Jadad scoreA 0–5 scale rating the methodological quality of a randomized trial based on randomization, blinding, and reporting of dropouts; 5 is the highest possible score.
Per-protocol analysisA statistical approach that analyzes only participants who completed the study as planned, rather than everyone originally enrolled.
Technical Study Details

Study Design

Duration8 weeks

Total Score

JADAD Quality Assessment
5
/ 5

評価詳細

Randomization

2 / 2
Is the study described as randomized?
Yes+1
Rationale: The article explicitly states the study was "randomised" and describes participants as "randomly assigned to two groups," along with details of the randomization process using an R software package, clearly meeting the criterion for Q1.
Is the method of randomization described and appropriate?
Yes+1
Rationale: The article explicitly describes the randomization method: participants were randomly assigned using the R software's randomizeR package, a computer-generated randomization procedure. This is a well-documented, appropriate method of randomization (analogous to computer-generated random number sequences), not an inappropriate quasi-random method like alternation, date of birth, or hospital number.

Blinding

2 / 2
Is the study described as double-blind?
Yes+1
Rationale: The abstract explicitly states the study was "randomised, double-blind and placebo-controlled," and the Methods section (2.1 Participants) reiterates that participants were "randomly assigned to two groups in a double-blind manner." This directly satisfies the criterion for Q3.
Is the method of blinding described and appropriate?
Yes+1
Rationale: The article explicitly describes the blinding method: placebo capsules were manufactured by the same manufacturer and were identical in appearance (size, shape, and colour) to the ashwagandha capsules. This is an appropriate double-blinding method consistent with Jadad criteria for adequate blinding (identical-appearing placebo).

Dropouts/Withdrawals

1 / 1
Is there a description of dropouts and withdrawals?
Yes+1
Rationale: The Methods section (2.1 Participants) explicitly states the initial group sizes (20 Ashwagandha, 21 Placebo), the number of withdrawals per group (2 from Ashwagandha, 1 from Placebo), the reason for withdrawal ("personal reasons"), and the final analyzed sample sizes (18 Ashwagandha, 20 Placebo). This meets the Jadad Q5 criterion of describing the number and reasons for withdrawals/dropouts for each treatment group.

Study Population

Sample Size41
Age Range-
ConditionHealthy young men (physical education students) undergoing high-intensity interval training
Inclusion Criteria
  • Not engaged in competitive sports
  • Not participating in any regular training programme for at least 12 months prior to enrolment
  • Attending practical classes included in their study curriculum (physical education students)

Interventions

Ashwagandha KSM-66 root extract

Treatment
Dose600 mg/day (2 x 300 mg capsules, standardised to 5% withanolides by HPLC)
FrequencyTwice daily, after breakfast and dinner
Duration8 weeks
Routeoral

Placebo

Control
Dose2 capsules/day
FrequencyTwice daily, after breakfast and dinner
Duration8 weeks
Routeoral

High-Intensity Interval Training (HIIT)

Treatment
Frequency3 sessions per week, at least 1 rest day between sessions
Duration8 weeks
RouteN/A

Outcomes

OutcomeTypeEffectp-value
Body weightSecondary->0.05
Fat mass (FM)Secondary->0.05
Muscle mass (MM, skeletal muscle tissue)Secondary->0.05
Total body water (TBW)Secondary->0.05
Total cholesterol (tChol)Primary->0.05
HDL-cholesterolPrimary->0.05
LDL-cholesterolPrimary->0.05
Triglycerides (TG)Primary->0.05
AdiponectinPrimary-<0.05Significant
AsprosinPrimary--
IrisinPrimary-<0.0001Significant

Safety

Adverse Events0
Serious AEs0
Dropout Rate7.3%
In both the ashwagandha and placebo groups, no adverse effects were reported, and good tolerance of the ingested capsules was reported.

Conclusion

In young, healthy men, an 8-week HIIT programme significantly decreased resting adiponectin levels and increased irisin levels post-exercise and after 24h recovery, indicating effects on hormones related to energy metabolism of adipose (adiponectin) and muscle (irisin) tissue. However, ashwagandha supplementation (600 mg/day) combined with 8-week HIIT did not produce additional significant effects on body composition, lipid profile, or any of the hormonal parameters analysed (adiponectin, asprosin, irisin) compared to placebo.

Limitations

  • Dietary assessment relied on participant self-recording of food intake, which may be biased by self-assessment
  • Study population limited to healthy young men only, limiting generalisability to other populations (e.g., older women and men, overweight/obese individuals)
  • Lack of prior studies on ashwagandha supplementation combined with HIIT in healthy individuals made comparison of results difficult
  • Possible that a longer supplementation period than 8 weeks may be needed to observe benefits in a physically active, healthy population undergoing intense training
  • Sample size, though meeting the a priori power calculation (n=34), was relatively modest with three dropouts (two in Ashwagandha, one in Placebo group)
This content was generated by AI (LLM). While we strive for accuracy, please verify important information with the original source.
Ashwagandha + HIIT: An 8-Week Trial Finds the Popular "Adaptogen Stack" Adds Nothing to Cholesterol, Body Composition, or Exercise Hormones | Re:Vital Nexus